Symmetry Medical, Inc. (SMA) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts SMA Hot Sheet
Join SI Premium – FREE
Symmetry Medical, Inc. (NYSE: SMA) reported Q2 EPS of $0.14, $0.01 better than the analyst estimate of $0.13. Revenue for the quarter came in at $102.3 million versus the consensus estimate of $102.98 million.
Symmetry Medical, Inc. sees FY2012 EPS of $0.55-$0.65, versus the consensus of $0.54. Symmetry Medical, Inc. sees FY2012 revenue of $410-$425 million, versus the consensus of $418.2 million.
For earnings history and earnings-related data on Symmetry Medical, Inc. (SMA) click here.
Symmetry Medical, Inc. sees FY2012 EPS of $0.55-$0.65, versus the consensus of $0.54. Symmetry Medical, Inc. sees FY2012 revenue of $410-$425 million, versus the consensus of $418.2 million.
For earnings history and earnings-related data on Symmetry Medical, Inc. (SMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
